Amylyx Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Amylyx Pharmaceuticals's estimated annual revenue is currently $28.2M per year.
- Amylyx Pharmaceuticals's estimated revenue per employee is $59,265
- Amylyx Pharmaceuticals's total funding is $172M.
Employee Data
- Amylyx Pharmaceuticals has 476 Employees.
- Amylyx Pharmaceuticals grew their employee count by 32% last year.
Amylyx Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & Co-CEO | Reveal Email/Phone |
2 | CEO and Founder | Reveal Email/Phone |
3 | Head Global Talent Attraction | Reveal Email/Phone |
4 | Head, US ALS Marketing | Reveal Email/Phone |
5 | Head Global Marketing | Reveal Email/Phone |
6 | Head, US Patient Support | Reveal Email/Phone |
7 | Head, Strategic Payer Accounts | Reveal Email/Phone |
8 | Head Talent & HR Business Partnering | Reveal Email/Phone |
9 | Head, US Commercial Distribution | Reveal Email/Phone |
10 | Head, Corporate Accounting | Reveal Email/Phone |
Amylyx Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Amylyx Pharmaceuticals?
Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.
keywords:N/A
$172M
Total Funding
476
Number of Employees
$28.2M
Revenue (est)
32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Amylyx Pharmaceuticals News
Shares of Amylyx Pharmaceuticals ( AMLX -8.81% ), a clinical-stage biopharmaceutical company, are tanking in response to comments from the...
Shares of Amylyx Pharmaceuticals lost more than half of their value after the Food and Drug Administration issued a skeptical analysis of...
... convening a meeting of outside experts today to review clinical data on an experimental treatment for ALS from Amylyx Pharmaceuticals.
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $62.1M | 487 | 6% | N/A |
#2 | N/A | 489 | 32% | N/A |
#3 | $129.2M | 492 | 0% | N/A |
#4 | $7.5M | 500 | 58% | N/A |
#5 | $203.2M | 500 | 0% | $119.8M |